Genistein up-regulates the iron efflux system in glial cells

Neuroscience Letters

Volumn 470, Issue 2, 2010, Pages 145-149

  Persichini, Tiziana ^a   Maio, Nunziata ^a   Bonaccorsi di Patti, Maria Carmela ^b   Rizzo, Gianluca ^a   Colasanti, Marco ^a   Musci, Giovanni ^a,c  

^a ROMA TRE UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF MOLISE   (Italy)

Author keywords

Astrocyte; Ceruloplasmin; Ferroportin; Genistein; Iron

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CERULOPLASMIN; ESTROGEN RECEPTOR BETA; FERROPORTIN 1; GENISTEIN; IRON; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; GLIA CELL; HUMAN; HUMAN CELL; IRON TRANSPORT; OXIDATIVE STRESS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

CATION TRANSPORT PROTEINS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE, TUMOR; CERULOPLASMIN; ESTROGEN RECEPTOR BETA; GENISTEIN; HUMANS; IRON; MALE; NEUROGLIA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHYTOESTROGENS; UP-REGULATION;

EID: 74449092876     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.12.074     Document Type: Article

References (42)

1. Acconcia F., and Kumar R. Signaling regulation of genomic and nongenomic functions of estrogen receptors. Cancer Lett. 238 (2006) 1-14
2. Acconcia F., Totta P., Ogawa S., Cardillo I., Inoue S., Leone S., Trentalance A., Muramatsu M., and Marino M. Survival versus apoptotic 17beta-estradiol effect: role of ER alpha and ER beta activated non-genomic signaling. J. Cell Physiol. 203 (2005) 193-201
3. Anderson G.J., and Vulpe C.D. Mammalian iron transport. Cell Mol. Life Sci. 66 (2009) 3241-3261
4. Arora A., Nair M.G., and Strasburg G.M. Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch. Biochem. Biophys. 356 (1998) 133-141
5. Berg D., and Youdim M.B. Role of iron in neurodegenerative disorders. Top. Magn Reson. Imaging 17 (2006) 5-17
6. Bingle C.D., Fleming R.E., and Gitlin J.D. Interaction of CCAAT/enhancer-binding protein alpha and beta with the rat caeruloplasmin gene promoter. Biochem. J. 294 Pt 2 (1993) 473-479
7. Bonaccorsi di Patti M.C., Persichini T., Mazzone V., Polticelli F., Colasanti M., and Musci G. Interleukin-1beta up-regulates iron efflux in rat C6 glioma cells through modulation of ceruloplasmin and ferroportin-1 synthesis. Neurosci. Lett. 363 (2004) 182-186
8. Brown A., Jolly P., and Wei H. Genistein modulates neuroblastoma cell proliferation and differentiation through induction of apoptosis and regulation of tyrosine kinase activity and N-myc expression. Carcinogenesis 19 (1998) 991-997
9. Carosio R., Zuccari G., Orienti I., Mangraviti S., and Montaldo P.G. Sodium ascorbate induces apoptosis in neuroblastoma cell lines by interfering with iron uptake. Mol. Cancer 6 (2007) 55
10. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., and Lee J.C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364 (1995) 229-233
11. Das A., Banik N.L., and Ray S.K. Mechanism of apoptosis with the involvement of calpain and caspase cascades in human malignant neuroblastoma SH-SY5Y cells exposed to flavonoids. Int. J. Cancer 119 (2006) 2575-2585
12. De Domenico I., Ward D.M., Bonaccorsi di Patti M.C., Jeong S.Y., David S., Musci G., and Kaplan J. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J. 26 (2007) 2823-2831
13. Dringen R., Bishop G.M., Koeppe M., Dang T.N., and Robinson S.R. The pivotal role of astrocytes in the metabolism of iron in the brain. Neurochem. Res. 32 (2007) 1884-1890
14. Dunn L.L., Rahmanto Y.S., and Richardson D.R. Iron uptake and metabolism in the new millennium. Trends Cell Biol. 17 (2007) 93-100
15. Facello B., Castaldo L., De M.L., and Lucini C. Glial cell line-derived neurotrophic factor in Purkinje cells of adult zebrafish: an autocrine mode of action?. Neurosci. Lett. 465 (2009) 133-137
16. Fleming R.E., and Gitlin J.D. Structural and functional analysis of the 5′-flanking region of the rat ceruloplasmin gene. J. Biol. Chem. 267 (1992) 479-486
17. Gaasch J.A., Lockman P.R., Geldenhuys W.J., Allen D.D., and Van der Schyf C.J. Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells. Neurochem. Res. 32 (2007) 1196-1208
18. Harris Z.L., Takahashi Y., Miyajima H., Serizawa M., MacGillivray R.T., and Gitlin J.D. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 2539-2543
19. Hayflick S.J. Neurodegeneration with brain iron accumulation: from genes to pathogenesis. Semin. Pediatr. Neurol. 13 (2006) 182-185
20. Ho K.P., Li L., Zhao L., and Qian Z.M. Genistein protects primary cortical neurons from iron-induced lipid peroxidation. Mol. Cell. Biochem. 247 (2003) 219-222
21. Howell A., Osborne C.K., Morris C., and Wakeling A.E. ICI 182,780 (Faslodex): development of a novel, "pure" antiestrogen. Cancer 89 (2000) 817-825
22. Kaneko K., Yoshida K., Arima K., Ohara S., Miyajima H., Kato T., Ohta M., and Ikeda S.I. Astrocytic deformity and globular structures are characteristic of the brains of patients with aceruloplasminemia. J. Neuropathol. Exp. Neurol. 61 (2002) 1069-1077
23. Karin M., and Delhase M. JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action?. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 9067-9069
24. Katzenellenbogen B.S., Montano M.M., Ediger T.R., Sun J., Ekena K., Lazennec G., Martini P.G., McInerney E.M., Delage-Mourroux R., Weis K., and Katzenellenbogen J.A. Estrogen receptors: selective ligands, partners, and distinctive pharmacology. Recent Prog. Horm. Res. 55 (2000) 163-193
25. Kim H., Xia H., Li L., and Gewin J. Attenuation of neurodegeneration-relevant modifications of brain proteins by dietary soy. Biofactors 12 (2000) 243-250
26. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der B.B., and Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139 (1998) 4252-4263
27. Lee Y.B., Lee H.J., and Sohn H.S. Soy isoflavones and cognitive function. J. Nutr. Biochem. 16 (2005) 641-649
28. Meyer M.R., Haas E., Prossnitz E.R., and Barton M. Non-genomic regulation of vascular cell function and growth by estrogen. Mol. Cell. Endocrinol. 308 (2009) 9-16
29. Mohan N., Karmakar S., Choudhury S.R., Banik N.L., and Ray S.K. Bcl-2 inhibitor HA14-1 and genistein together adeptly down regulated survival factors and activated cysteine proteases for apoptosis in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells. Brain Res. 1283 (2009) 155-166
30. Molina-Holgado F., Hider R.C., Gaeta A., Williams R., and Francis P. Metals ions and neurodegeneration. Biometals 20 (2007) 639-654
31. Nilsson S., Makela S., Treuter E., Tujague M., Thomsen J., Andersson G., Enmark E., Pettersson K., Warner M., and Gustafsson J.A. Mechanisms of estrogen action. Physiol. Rev. 81 (2001) 1535-1565
32. Patel B.N., and David S. A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J. Biol. Chem. 272 (1997) 20185-20190
33. Peyssonnaux C., and Eychene A. The Raf/MEK/ERK pathway: new concepts of activation. Biol. Cell 93 (2001) 53-62
34. Ponten J., and Macintyre E.H. Long term culture of normal and neoplastic human glia. Acta Pathol. Microbiol. Scand. 74 (1968) 465-486
35. Ramey G., Deschemin J.C., and Vaulont S. Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes. Haematologica 94 (2009) 765-772
36. Stuckey R., Aldridge T., Lim F.L., Moore D.J., Tinwell H., Doherty N., Davies R., Smith A.G., Kimber I., Ashby J., Orphanides G., and Moggs J.G. Induction of iron homeostasis genes during estrogen-induced uterine growth and differentiation. Mol. Cell. Endocrinol. 253 (2006) 22-29
37. Taguchi Y., Koslowski M., and Bodenner D.L. Binding of estrogen receptor with estrogen conjugated to bovine serum albumin (BSA). Nucl. Recept. 2 (2004) 5
38. Totta P., Acconcia F., Leone S., Cardillo I., and Marino M. Mechanisms of naringenin-induced apoptotic cascade in cancer cells: involvement of estrogen receptor alpha and beta signalling. IUBMB Life 56 (2004) 491-499
39. Totta P., Acconcia F., Virgili F., Cassidy A., Weinberg P.D., Rimbach G., and Marino M. Daidzein-sulfate metabolites affect transcriptional and antiproliferative activities of estrogen receptor-beta in cultured human cancer cells. J. Nutr. 135 (2005) 2687-2693
40. Wei H., Bowen R., Cai Q., Barnes S., and Wang Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc. Soc. Exp. Biol. Med. 208 (1995) 124-130
41. Yoshida K., Furihata K., Takeda S., Nakamura A., Yamamoto K., Morita H., Hiyamuta S., Ikeda S., Shimizu N., and Yanagisawa N. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat. Genet. 9 (1995) 267-272
42. Yu H.L., Li L., Zhang X.H., Xiang L., Zhang J., Feng J.F., and Xiao R. Neuroprotective effects of genistein and folic acid on apoptosis of rat cultured cortical neurons induced by beta-amyloid 31-35. Br. J. Nutr. 102 (2009) 655-662